Recently, we have demonstrated that activation of Wnt signalling via GSK3β inhibition in metastatic and androgen independent prostate cancer cells (PC3, DU145, and C4-2B) induces dramatic changes in their morphology, blocks their migration, reduces their metastatic growth, and strongly affects their mesenchymal phenotype [31]. The gene discussed is GSK3B; the disease is prostate cancer.